Structured Summary
Abstract
The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis.
MeSH Record
Classification
Broader headings
Narrower headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
13 entry terms
- Pharmaceutical Design
- Design, Pharmaceutical
- Drug Designs
- Pharmaceutical Designs
- Computer-Aided Drug Design
- Computerized Drug Design
- Drug Modeling
- Computer Aided Drug Design
- Computer-Aided Drug Designs
- Computerized Drug Designs
- Drug Design, Computer-Aided
- Drug Design, Computerized
- Drug Modelings
MeSH Record
Aspects Covered
10 allowable subheadings
Indexed with the subheadings classification, economics, ethics, history, instrumentation, methods, standards, statistics & numerical data, trends, veterinary.
MeSH Record
Indexing Annotation
do not confuse with DESIGNER DRUGS
MeSH Record
History Note
89
MeSH Record
Previous Indexing
- Chemistry, Pharmaceutical (1966-1988)
- Drugs (1966-1988)
MeSH Hierarchy
Tree Number
MeSH Record
NLM Classification
QV 745
AMA Style
References
- National Library of Medicine. Drug Design. Medical Subject Headings (MeSH). 2026. Unique ID D015195. http://id.nlm.nih.gov/mesh/2026/D015195
- Drug Design. In: Wikipedia. https://en.wikipedia.org/wiki/Drug_design
- Drug Design. In: Wikidata. https://www.wikidata.org/wiki/Q2991682